AtriCure amends and restates 2023 stock incentive plan as of May 18, 2026
AtriCure, Inc. has filed an amended and restated version of its 2023 Stock Incentive Plan, which provides equity compensation and stock-based awards to directors, officers, employees, and consultants. The filing establishes plan definitions, eligibility criteria, and governance structure but contains no new share authorization amounts or material changes disclosed in this excerpt.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day